| 000 | 01926 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516034028.0 | ||
| 264 | 0 | _c20110930 | |
| 008 | 201109s 0 0 eng d | ||
| 022 | _a1439-1104 | ||
| 024 | 7 |
_a10.1007/s10158-011-0116-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBagatini, Pamela Brambilla | |
| 245 | 0 | 0 |
_aThe role of calcium channel blockers and resveratrol in the prevention of paraquat-induced parkinsonism in Drosophila melanogaster: a locomotor analysis. _h[electronic resource] |
| 260 |
_bInvertebrate neuroscience : IN _cJun 2011 |
||
| 300 |
_a43-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntioxidants _xadministration & dosage |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xadministration & dosage |
| 650 | 0 | 4 |
_aCalcium Channels _xdrug effects |
| 650 | 0 | 4 |
_aDihydropyridines _xadministration & dosage |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 |
_aDrosophila melanogaster _xmetabolism |
| 650 | 0 | 4 |
_aNerve Degeneration _xchemically induced |
| 650 | 0 | 4 | _aParaquat |
| 650 | 0 | 4 |
_aParkinsonian Disorders _xchemically induced |
| 650 | 0 | 4 | _aResveratrol |
| 650 | 0 | 4 |
_aStilbenes _xadministration & dosage |
| 650 | 0 | 4 |
_aSubstantia Nigra _xcytology |
| 700 | 1 | _aSaur, Lisiani | |
| 700 | 1 | _aRodrigues, Mariana Freitas | |
| 700 | 1 | _aBernardino, Guilherme Cardoso | |
| 700 | 1 | _aPaim, Mariana Fontoura | |
| 700 | 1 | _aCoelho, Guilherme Peres | |
| 700 | 1 | _aSilva, Daniele Vieira da | |
| 700 | 1 | _ade Oliveira, Raquel Mattos | |
| 700 | 1 | _aSchirmer, Helena | |
| 700 | 1 | _aSouto, André Arigony | |
| 700 | 1 | _aVianna, Mônica Ryff Moreira Roca | |
| 700 | 1 | _aXavier, Léder Leal | |
| 773 | 0 |
_tInvertebrate neuroscience : IN _gvol. 11 _gno. 1 _gp. 43-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10158-011-0116-3 _zAvailable from publisher's website |
| 999 |
_c20788276 _d20788276 |
||